Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA ad hotline

Executive Summary

As of Aug. 2, FDA received 2,016 calls or an average of 44 a week, FDA Medicine Staff Director Peter Rheinstein, MD, tells FDLI Sept. 14. The 800-number was set up in September 1991 primarily to handle complaints about promotions, but Rheinstein notes that "a relatively small percentage, just under 10%" of calls concern marketing and advertising. About 63% concern drug approval or usage questions and quite a number concern medication errors. Reviewing calls between May 4 and Aug. 2, FDA found 21% of calls came from pharmacists, 19% from physicians, 13% from consumers, 12% from nurses and 1% from veterinarians.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021485

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel